Latest Whitepapers

With time a precious commodity and ever-increasing regulatory scrutiny, pharmaceutical laboratories are always on the lookout for simple solutions to make their routine tasks easier.

Gene therapy is rapidly gaining importance as a critical treatment modality in the prevention or cure of a wide range of diseases. However, getting a product to market for commercial use does not come without its challenges.

Download this whitepaper to discover how next-generation ELISA technology can accelerate biomarker discovery and provide in-depth analysis of COVID-19 host cytokine levels.

Download this whitepaper to learn how Octet® Bio-Layer Interferometry (BLI) assays can accelerate the advancement of lead compounds to in vivo validation studies.

Download this whitepaper to discover how a LIMS can schedule and monitor microbial testing whilst maintaining compliance and capturing results from numerous instruments.

Screening tests are intended to identify infected individuals who may be contagious, regardless of whether they are displaying symptoms, so that measures can be taken to prevent those individuals from infecting others.

Download this whitepaper to learn more about how dilutional linearity enhances reliability, undetected HCP can be minimized as well as consistently low variation ensures reproducible data.

Download this whitepaper to learn more about antibody engineering design parameters, different options including humanization and fragments as well as the future of antibody engineering.

Download this whitepaper to discover how third generation sequencing can identify disease-causing variants with complex genetic etiology, detect SARS-CoV-2 and provide novel genetic insights.

Assays, such as the enzyme-linked immunosorbent assay (ELISA), are being developed to detect the presence of anti-SARS-CoV-2 antibodies in patient sera. Download this article to discover an ELISA that is more sensitive than a lateral flow immunoassay.